ALNYLAM PHARMACEUTICALS, INC. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Dec 16, 2014
Insider Transaction Report
Form 4
Reid Laurence
SVP, Chief Business Officer
Transactions
- Award
Performance Based Stock Option (right to buy)
2014-12-12+6,667→ 6,667 totalExercise: $63.00From: 2014-12-12Exp: 2023-12-18→ Common Stock (6,667 underlying)
Footnotes (1)
- [F1]On December 18, 2013, the reporting person was granted a performance based stock option to purchase shares of ALNY Common Stock. One-third of the shares subject to the option will vest upon the achievement of each of three specific clinical development and regulatory events, as approved by our compensation committee. Effective December 12, 2014, the compensation committee of the Company determined the first performance criteria had been met and the option will vest as to one-third of the shares.